• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bicycle Therapeutics Plc ADR (NQ: BCYC )

    22.73 +0.39 (+1.75%)
    Streaming Delayed Price Updated: 11:08 AM EDT, Aug 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Bicycle Therapeutics Plc ADR

    < Previous 1 2 3 4 5 6 Next >
    Bicycle Therapeutics Announces Continued Clinical Progress and Updates to Management Team
    From Bicycle Therapeutics plc
    Via Business Wire
    Best Stocks Of 2021: Meme Stocks, Biotechs Highlight Broad Sector Strength
    The list features stocks from diverse sectors as the economy recovers from the pandemic. 
    Via Investor's Business Daily
    7 A-Rated Biotechs to Buy for the Long Run
    The one thing the pandemic has shown us is biotechs are changing the way we treat diseases. These A-rated biotechs are great examples. 
    Via InvestorPlace
    Bicycle Therapeutics to Participate in Upcoming Investor Conferences
    From Bicycle Therapeutics plc
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021
    Upgrades According to Morgan Stanley, the prior rating for Definitive Healthcare Corp (NASDAQ: 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
    Upgrades According to BMO Capital, the prior rating for Nuvei Corp (NASDAQ: 
    Via Benzinga
    Bicycle Therapeutics to Present Four Posters Highlighting Preclinical Data from its Bicycle Tumor-Targeted Immune Cell Agonist™ (Bicycle TICA™) Programs at the SITC 36th Annual Meeting
    From Bicycle Therapeutics plc
    Via Business Wire
    Looking Into Bicycle Therapeutics's Return On Capital Employed
    According to Benzinga Pro data, during Q3, Bicycle Therapeutics (NASDAQ:BCYC) posted sales of $4.33 million. Earnings were up 17.27%, but Bicycle Therapeutics still reported an... 
    Via Benzinga
    Bicycle Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
    From Bicycle Therapeutics plc
    Via Business Wire
    Bicycle Therapeutics Announces First Patient Dosed in Phase I/II Trial of Bicycle® Tumor-targeted Immune Cell Agonist™ BT7480 in Patients with Advanced Solid Tumors Associated with Nectin-4 Expression
    From Bicycle Therapeutics plc
    Via Business Wire
    Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT7480 Program in the Journal for ImmunoTherapy of Cancer
    From Bicycle Therapeutics plc
    Via Business Wire
    Bicycle Therapeutics Announces Expansion of Genentech Immuno-Oncology Collaboration
    From Bicycle Therapeutics plc
    Via Business Wire
    Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    From Bicycle Therapeutics plc
    Via Business Wire
    Bicycle Therapeutics Announces Pricing of Upsized Public Offering of $175 Million of American Depositary Shares
    From Bicycle Therapeutics plc
    Via Business Wire
    The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:... 
    Via Benzinga
    Exposures COVID-19
    Bicycle Therapeutics Announces Proposed $125,000,000 Public Offering of American Depositary Shares
    From Bicycle Therapeutics plc
    Via Business Wire
    45 Biggest Movers From Yesterday
    Gainers Camber Energy, Inc.. (NYSE: CEI) shares surged 95.9% to close at $1.78 on Thursday after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial... 
    Via Benzinga
    The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... 
    Via Benzinga
    Exposures Product Safety
    Bicycle Therapeutics Stock Falls After Interim Data Of Toxin Conjugates In Ovarian Cancer Trial
    Bicycle Therapeutics plc (NASDAQ: BCYC) has reported interim Phase I trial results for BT5528 and preliminary findings from the ongoing dose-escalation portion of... 
    Via Benzinga
    Bicycle Therapeutics Announces Interim BT5528 Phase I Clinical Trial Results and Preliminary Results from Ongoing BT8009 Phase I Clinical Trial
    From Bicycle Therapeutics plc
    Via Business Wire
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Gainers Voyager Therapeutics (NASDAQ:VYGR) shares moved upwards by 44.73% to $3.58 during Wednesday's regular session. Voyager Therapeutics's stock is trading at a... 
    Via Benzinga
    The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs, And More
    Biotech stocks came under pressure in the week ending Oct. 1, dragged by broader market weakness and the selling of vaccine stocks. Here are the key catalysts that could move stocks in the unfolding... 
    Via Talk Markets
    Exposures Product Safety
    The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... 
    Via Benzinga
    The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... 
    Via Benzinga
    The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
    Biotech stocks came under pressure in the week ending Oct. 1, dragged by broader market weakness and the selling of vaccine stocks. Positive tidings from Merck & Co... 
    Via Benzinga
    Exposures Product Safety
    Bicycle Therapeutics to Present BT5528 Interim Phase I Data at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
    From Bicycle Therapeutics plc
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2021
    Upgrades For Cabot Oil & Gas Corp (NYSE:COG),... 
    Via Benzinga
    The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (... 
    Via Benzinga
    The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... 
    Via Benzinga
    The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.